An acetylated derivative of vitexin halts MDA-MB-231 cellular progression and improves its immunogenic profile through tuning miR- 20a-MICA/B axis

References

• Aaltomaa S, Lipponen P. 1992. Lymphocyte infiltrates as a prognostic variable in female breast cancer. Eur J Cancer. 28A(4–5):859–864.
   PubMed Web of Science ®Google Scholar
• Abdelhady MIS, Motaal AA. 2016. A cytotoxic C-glycosylated derivative of apigenin from the leaves of Ocimum basilicum var. thyrsiflorum. Braz J Pharmacogn. 26(6):763–766.
   Web of Science ®Google Scholar
• Bai X, Han G, Liu Y, Jiang H, He Q. 2018. MiRNA-20a-5p promotes the growth of triple-negative breast cancer cells through targeting RUNX3. Biomed Pharmacother. 103:1482–1489.
   PubMed Web of Science ®Google Scholar
• Braedel-Ruoff S. 2010. Immunomodulatory effects of Viscum album extracts on natural killer cells: review of clinical trials. Forsch Komplementmed. 17(2):63–73.
   PubMedGoogle Scholar
• Cerwenka A, Lanier LL. 2016. Natural killer cell memory in infection, inflammation and cancer. Nat Rev Immunol. 16(2):112–123.
   PubMed Web of Science ®Google Scholar
• Chalakur-Ramireddy NKR, Pakala SB. 2018. Combined drug therapeutic strategies for the effective treatment of triple negative breast cancer. Biosci Rep. 38(1). doi:https://doi.org/10.1042/BSR20171357.
   Google Scholar
• Dunn GP, Koebel CM, Schreiber RD. 2006. Interferons, immunity and cancer immunoediting. Nat Rev Immunol. 6(11):836–848.
   PubMed Web of Science ®Google Scholar
• Eissmann P, Evans JH, Mehrabi M, Rose EL, Nedvetzki S, Davis DM. 2010. Multiple mechanisms downstream of TLR-4 stimulation allow expression of NKG2D ligands to facilitate macrophage/NK cell crosstalk. J Immunol. 184(12):6901–6909.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. 2015. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136(5):E359–E386.
   PubMed Web of Science ®Google Scholar
• Ganesan K, Xu B. 2017. Molecular targets of vitexin and isovitexin in cancer therapy: a critical review. Ann NY Acad Sci. 1401(1):102–113.
   PubMed Web of Science ®Google Scholar
• Ghadially H, Brown L, Lloyd C, Lewis L, Lewis A, Dillon J, Sainson R, Jovanovic J, Tigue NJ, Bannister D, et al. 2017. MHC class I chain-related protein A and B (MICA and MICB) are predominantly expressed intracellularly in tumour and normal tissue. Br J Cancer. 116(9):1208–1217.
   PubMed Web of Science ®Google Scholar
• Gonzalez S, Lopez-Soto A, et al. 2008. NKG2D ligands: key targets of the immune response. Trends Immunol. 29(8):397–403.
   PubMed Web of Science ®Google Scholar
• Grudzien M, Rapak A. 2018. Effect of natural compounds on NK cell activation. J Immunol Res. 2018. doi:https://doi.org/10.1155/2018/4868417.
   Google Scholar
• Guo TL, White KL, Brown RD, Delclos KB, Newbold RR, Weis C, Germolec DR, McCay JA Jr. 2002. Genistein modulates splenic natural killer cell activity, antibody-forming cell response, and phenotypic marker expression in F(0) and F(1) generations of Sprague-Dawley rats. Toxicol Appl Pharmacol. 181(3):219–227.
   PubMed Web of Science ®Google Scholar
• Hien TV, Huong NB, Hung PM, Duc NB. 2002. Radioprotective effects of vitexina for breast cancer patients undergoing radiotherapy with cobalt-60. Integr Cancer Ther. 1(1):38–34.
   PubMedGoogle Scholar
• Kiessling R, Klein E, Pross H, Wigzell H. 1975. “Natural” killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur J Immunol. 5(2):117–121.
   PubMed Web of Science ®Google Scholar
• Krol J, Loedige I, Filipowicz W. 2010. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 11(9):597–610.
   PubMed Web of Science ®Google Scholar
• Li X, He C, Liu C, Ma J, Ma PAN, Cui H, Tao HUA, Gao BIN. 2015. Expansion of NK cells from PBMCs using immobilized 4-1BBL and interleukin-21. Int J Oncol. 47(1):335–342.
   PubMed Web of Science ®Google Scholar
• Lu CC, Chen JK. 2010. Resveratrol enhances perforin expression and NK cell cytotoxicity through NKG2D-dependent pathways. J Cell Physiol. 223(2):343–351.
   PubMed Web of Science ®Google Scholar
• Pegram HJ, Andrews DM, Smyth MJ, Darcy PK, Kershaw MH. 2011. Activating and inhibitory receptors of natural killer cells. Immunol Cell Biol. 89(2):216–224.
   PubMed Web of Science ®Google Scholar
• Qiang X-F, Zhang Z-W, Liu Q, Sun N, Pan L-L, Shen J, Li T, Yun C, Li H, Shi L-H. 2014. miR-20a promotes prostate cancer invasion and migration through targeting ABL2. J Cell Biochem. 115(7):1269–1276.
   PubMed Web of Science ®Google Scholar
• Salih HR, Rammensee H-G, Steinle A. 2002. Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding. J Immunol. 169(8):4098–4102.
   PubMed Web of Science ®Google Scholar
• Shen J, Pan J, Du C, Si W, Yao M, Xu L, Zheng H, Xu M, Chen D, Wang S, et al. 2017. Silencing NKG2D ligand-targeting miRNAs enhances natural killer cell-mediated cytotoxicity in breast cancer. Cell Death Dis. 8(4):e2740.
   PubMed Web of Science ®Google Scholar
• Sobral MV, Xavier AL, Lima TC, de Sousa DP. 2014. Antitumor activity of monoterpenes found in essential oils. Sci World J. 2014. doi:https://doi.org/10.1155/2014/953451.
   Google Scholar
• Verma V, Sprave T, Haque W, Simone CB, Chang JY, Welsh JW, Thomas CR. 2018. A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors. J Immunother Cancer. 6(1):128.
   PubMed Web of Science ®Google Scholar
• Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. 2008. Functions of natural killer cells. Nat Immunol. 9(5):503–510.
   PubMed Web of Science ®Google Scholar
• Xie J, Liu M, Li Y, Nie Y, Mi Q, Zhao S. 2014. Ovarian tumor-associated microRNA-20a decreases natural killer cell cytotoxicity by downregulating MICA/B expression. Cell Mol Immunol. 11(5):495–502.
   PubMed Web of Science ®Google Scholar
• Youness RA, Assal RA, Ezzat SM, Gad MZ, Abdel Motaal A. 2018. A methoxylated quercetin glycoside harnesses HCC tumor progression in a TP53/miR-15/miR-16 dependent manner. Nat Prod Res. 1–6.
   PubMed Web of Science ®Google Scholar
• Zhang G-J, Li YU, Zhou HE, Xiao H-X, Zhou T. 2014. miR20a is an independent prognostic factor in colorectal cancer and is involved in cell metastasis. Mol Med Rep. 10(1):283–291.
   PubMed Web of Science ®Google Scholar